1
|
Ferlay J, Ervik M, Lam F, Colombet M, Mery
L, Pineros M, Znaor A, Soerjomataram I and Bray F: Global Cancer
Observatory: Cancer Today. International Agency for Research on
Cancer; Lyon: 2018
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Silver MI and Kobrin S: Exacerbating
disparities? Cervical cancer screening and HPV vaccination. Prev
Med. 130:1059022020. View Article : Google Scholar : PubMed/NCBI
|
4
|
Cervical cancer analysis reveals new
mutations. Cancer Discov. 7:3442017.
|
5
|
Kailash U, Soundararajan CC, Lakshmy R,
Arora R, Vivekanandhan S and Das BC: Telomerase activity as an
adjunct to high-risk human papillomavirus types 16 and 18 and
cytology screening in cervical cancer. Br J Cancer. 95:1250–1257.
2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sharma A, Rajappa M, Saxena A and Sharma
M: Telomerase activity as a tumor marker in Indian women with
cervical intraepithelial neoplasia and cervical cancer. Mol Diagn
Ther. 11:193–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Li C, Ma C, Zhang W and Wang J: The immune
function differences and high-risk human papillomavirus infection
in the progress of cervical cancer. Eur J Gynaecol Oncol.
35:557–561. 2014.PubMed/NCBI
|
8
|
Lindström AK and Hellberg D:
Immunohistochemical LRIG3 expression in cervical intraepithelial
neoplasia and invasive squamous cell cervical cancer: Association
with expression of tumor markers, hormones, high-risk
HPV-infection, smoking and patient outcome. Eur J Histochem.
58:22272014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Falletta P, Sanchez-del-Campo L, Chauhan
J, Effern M, Kenyon A, Kershaw CJ, Siddaway R, Lisle R, Freter R,
Daniels MJ, et al: Translation reprogramming is an evolutionarily
conserved driver of phenotypic plasticity and therapeutic
resistance in melanoma. Genes Deve. 31:18–33. 2017. View Article : Google Scholar
|
10
|
Wang F, Li L, Liu B, Chen Z and Li C:
Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as
a potential carrier to overcome multidrug resistance in cervical
and breast cancer. Biomed Pharmacother. 86:595–604. 2017.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Yang BR, Cheung KK, Zhou X, Xie RF, Cheng
PP, Wu S, Zhou ZY, Tang JY, Hoi PM, Wang YH and Lee SM:
Amelioration of acute myocardial infarction by saponins from flower
buds of Panax notoginseng via pro-angiogenesis and
anti-apoptosis. J Ethnopharmacol. 181:50–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang P, Zhang L, Yao J, Shi Y, Li P and
Ding K: An arabinogalactan from flowers of Panax notoginseng
inhibits angiogenesis by BMP2/Smad/Id1 signaling. Carbohydr Polym.
121:328–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Su P, Wang L, Du SJ, Xin WF and Zhang WS:
Advance in studies of Panax notoginseng saponins on
pharmacological mechanism of nervous system disease. Zhongguo Zhong
Yao Za Zhi. 39:4516–4521. 2014.(In Chinese). PubMed/NCBI
|
14
|
Xia W, Sun C, Zhao Y and Wu L:
Hypolipidemic and antioxidant activities of sanchi (Radix
notoginseng) in rats fed with a high fat diet. Phytomedicine.
18:516–520. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhao Y, Sun X, Yu X, Gao R and Yin L:
Saponins from Panax notoginseng leaves improve the symptoms
of aplastic anemia and aberrant immunity in mice. Biomed
Pharmacother. 102:959–965. 2018. View Article : Google Scholar : PubMed/NCBI
|
16
|
He NW, Zhao Y, Guo L, Shang J and Yang XB:
Antioxidant, antiproliferative, and Pro-apoptotic activities of a
Saponin extract derived from the roots of Panax notoginseng
(Burk.) F.H. Chen. J Med Food. 15:350–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yan Z, Zhu ZL, Wang HQ, Li W, Mi YX and
Liu CX: Pharmacokinetics of panaxatrol disuccinate sodium, a novel
anti-cancer drug from Panax notoginseng, in healthy
volunteers and patients with advanced solid tumors. Acta Pharmacol
Sin. 31:1515–1522. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wan CZ, Xie JT, Fishbein A, Aung HH, He H,
Mehendale SR, He TC, Du W and Yuan CS: Antiproliferative effects of
different plant parts of Panax notoginseng on SW480 human
colorectal cancer cells. Phytother Res. 23:6–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cong S, Xiang L, Yuan X, Bai D and Zhang
X: Notoginsenoside R1 up-regulates microRNA-132 to protect human
lung fibroblast MRC-5 cells from lipopolysaccharide-caused injury.
Int Immunopharmacol. 68:137–144. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ming P, Cai T, Li J, Ning Y, Xie S, Tao T
and Tang F: A novel arylbenzofuran induces cervical cancer cell
apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A
signaling pathway. Oncotarget. 7:41843–41856. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen DL, Engle JT, Griffin EA, Miller JP,
Chu W, Zhou D and Mach RH: Imaging Caspase-3 activation as a marker
of apoptosis-targeted treatment response in cancer. Mol Imaging
Biol. 17:384–393. 2014. View Article : Google Scholar
|
22
|
Wang Y, Luo W and Wang Y: PARP-1 and its
associated nucleases in DNA damage response. DNA Repair (Amst).
81:1026512019. View Article : Google Scholar : PubMed/NCBI
|
23
|
Caron MC, Sharma AK, O'Sullivan J, Myler
LR, Ferreira MT, Rodrigue A, Coulombe Y, Ethier C, Gagné JP,
Langelier MF, et al: Poly(ADP-ribose) polymerase-1 antagonizes DNA
resection at double-strand breaks. Nat Commun. 10:29542019.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update.
Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Todd MA, Huh MS and Picketts DJ: The
sub-nucleolar localization of PHF6 defines its role in rDNA
transcription and early processing events. Eur J Human Genet.
10:1453–1459. 2016. View Article : Google Scholar
|
26
|
Todd MA and Picketts DJ: PHF6 interacts
with the nucleosome remodeling and deacetylation (NuRD) complex. J
Proteome Res. 11:4326–4337. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wang J, Leung JWC, Gong Z, Feng L, Shi X
and Chen J: PHF6 regulates cell cycle progression by suppressing
ribosomal RNA synthesis. J Biol Chem. 288:3174–3183. 2013.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhao J, Cui L, Sun J, Xie Z, Zhang L, Ding
Z and Quan X: Notoginsenoside R1 alleviates oxidized low-density
lipoprotein-induced apoptosis, inflammatory response, and oxidative
stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis.
Cell Signall. 76:1097812020. View Article : Google Scholar
|
29
|
Zhong L, Zhou XL, Liu YS, Wang YM, Ma F,
Guo BL, Yan ZQ and Zhang QY: Estrogen receptor α mediates the
effects of notoginsenoside R1 on endotoxin-induced inflammatory and
apoptotic responses in H9c2 cardiomyocytes. Mol Med Rep.
12:119–126. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
He K, Yan L, Pan CS, Liu YY, Cui YC, Hu
BH, Chang X, Li Q, Sun K, Mao XW, et al: ROCK-dependent ATP5D
modulation contributes to the protection of notoginsenoside NR1
against ischemia-reperfusion-induced myocardial injury. Am J
Physiol Heart Circ Physiol. 307:H1764–H1776. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yu Y, Sun G, Luo Y, Wang M, Chen R, Zhang
J, Ai Q, Xing N and Sun X: Cardioprotective effects of
Notoginsenoside R1 against ischemia/reperfusion injuries by
regulating oxidative stress- and endoplasmic reticulum
stress-related signaling pathways. Sci Rep. 6:217302016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Peng Y, Li SN, Pei X and Hao K: The
multivariate regression statistics strategy to investigate
content-effect correlation of multiple components in Traditional
Chinese Medicine based on a partial least squares method.
Molecules. 23:5452018. View Article : Google Scholar
|
33
|
Li Y, Li Z, Jia Y, Ding B and Yu J: In
vitro Anti-hepatoma activities of Notoginsenoside R1 through
downregulation of tumor promoter miR-21. Dig Dis Sci. 65:1364–1375.
2019. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lee CY, Hsieh SL, Hsieh S, Tsai CC, Hsieh
LC, Kuo YH and Wu CC: Inhibition of human colorectal cancer
metastasis by notoginsenoside R1, an important compound from
Panax notoginseng. Oncol Rep. 37:399–407. 2017. View Article : Google Scholar : PubMed/NCBI
|
35
|
Limsuwanchote S, Wungsintaweekul J,
Yusakul G, Han JY, Sasaki-Tabata K, Tanaka H, Shoyama Y and
Morimoto S: Preparation of a monoclonal antibody against
Notoginsenoside R1, a distinctive saponin from Panax
notoginseng, and its application to indirect competitive ELISA.
Planta Medica. 80:337–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Sun HX, Chen Y and Ye Y: Ginsenoside Re
and notoginsenoside R1: Immunologic adjuvants with low haemolytic
effect. Chem Biodivers. 3:718–726. 2006. View Article : Google Scholar : PubMed/NCBI
|
37
|
Dwyer DJ, Camacho DM, Kohanski MA, Callura
JM and Collins JJ: Antibiotic-induced bacterial cell death exhibits
physiological and biochemical hallmarks of apoptosis. Mol Cell.
46:561–572. 2012. View Article : Google Scholar : PubMed/NCBI
|
38
|
Li Y, Zhou M, Hu Q, Bai XC, Huang W,
Scheres SH and Shi Y: Mechanistic insights into caspase-9
activation by the structure of the apoptosome holoenzyme. Proc Natl
Acad Sci USA. 114:1542–1547. 2017. View Article : Google Scholar : PubMed/NCBI
|
39
|
Funk K, Czauderna C, Klesse R, Becker D,
Hajduk J, Oelgeklaus A, Reichenbach F, Fimm-Todt F, Lauterwasser J,
Galle PR, et al: BAX redistribution induces apoptosis resistance
and selective stress sensitivity in human HCC. Cancers (Basel).
12:14372020. View Article : Google Scholar
|
40
|
Kulkarni S, Micci MA, Leser J, Shin C,
Tang SC, Fu YY, Liu L, Li Q, Saha M, Li C, et al: Adult enteric
nervous system in health is maintained by a dynamic balance between
neuronal apoptosis and neurogenesis. Proc Natl Acad Sci USA.
114:E3709–E3718. 2017. View Article : Google Scholar : PubMed/NCBI
|
41
|
Marchi S, Patergnani S, Missiroli S,
Morciano G, Rimessi A, Wieckowski MR, Giorgi C and Pinton P:
Mitochondrial and endoplasmic reticulum calcium homeostasis and
cell death. Cell Calcium. 69:62–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
42
|
Stadler J and Richly H: Regulation of DNA
repair mechanisms: How the chromatin environment regulates the DNA
damage response. Int J Mol Sci. 18:17152017. View Article : Google Scholar
|
43
|
Matsuoka S, Ballif BA, Smogorzewska A,
McDonald ER III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini
N, Lerenthal Y, et al: ATM and ATR substrate analysis reveals
extensive protein networks responsive to DNA damage. Science.
316:1160–1166. 2007. View Article : Google Scholar : PubMed/NCBI
|
44
|
Zheng L, Dai H, Zhou M, Li X, Liu C, Guo
Z, Wu X, Wu J, Wang C, Zhong J, et al: Polyploid cells rewire DNA
damage response networks to overcome replication stress-induced
barriers for tumour progression. Nat Commun. 3:8152012. View Article : Google Scholar : PubMed/NCBI
|
45
|
Lowndes NF and Toh GW: DNA repair: The
importance of phosphorylating histone H2AX. Curr Biol. 15:R99–R102.
2005. View Article : Google Scholar : PubMed/NCBI
|
46
|
Jakob B, Splinter J, Conrad S, Voss KO,
Zink D, Durante M, Löbrich M and Taucher-Scholz G: DNA
double-strand breaks in heterochromatin elicit fast repair protein
recruitment, histone H2AX phosphorylation and relocation to
euchromatin. Nucleic Acids Res. 39:6489–6499. 2011. View Article : Google Scholar : PubMed/NCBI
|
47
|
Müller B, Ellinwood NM, Lorenz B and
Stieger K: Detection of DNA double strand breaks by γH2AX does not
result in 53bp1 recruitment in mouse retinal tissues. Front
Neurosci. 12:2862018. View Article : Google Scholar : PubMed/NCBI
|
48
|
Zhang C, Mejia LA, Huang J, Valnegri P,
Bennett EJ, Anckar J, Jahani-Asl A, Gallardo G, Ikeuchi Y, Yamada
T, et al: The X-linked intellectual disability protein PHF6
associates with the PAF1 complex and regulates neuronal migration
in the mammalian brain. Neuron. 78:986–993. 2013. View Article : Google Scholar : PubMed/NCBI
|
49
|
Vallée D, Chevrier E, Graham GE, Lazzaro
MA, Lavigne PA, Hunter AG and Picketts DJ: A novel PHF6 mutation
results in enhanced exon skipping and mild
Borjeson-Forssman-Lehmann syndrome. J Med Genet. 41:778–783. 2004.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Rocha CRR, Silva MM, Quinet A, Cabral-Neto
JB and Menck CFM: DNA repair pathways and cisplatin resistance: An
intimate relationship. Clinics (Sao Paulo). 73 (Suppl 1):e478s2018.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Salehan MR and Morse HR: DNA damage repair
and tolerance: A role in chemotherapeutic drug resistance. Br J
Biomed Sci. 70:31–40. 2016. View Article : Google Scholar
|